Orchard Pharmaceuticals Company Inc is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. ORCHARD PHARMACEUTICALS'S portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, Ebola, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.
Our portfolio of marketed products includes a number of category firsts, Inc luding complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Collaborations of all kinds – with partners in science, academia, business and local communities – are central to our work. Partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible.
Orchard Pharmaceuticals Company , Inc was founded in 1987 in Madrid, Spain. Since then, we have grown to become one of the world’s largest biopharmaceutical companies, with more than 7,000 employees across six continents.